Year |
Citation |
Score |
2016 |
Shenkar R, Shi C, Austin C, Moore T, Lightle R, Cao Y, Zhang L, Wu M, Zeineddine HA, Girard R, McDonald DA, Rorrer A, Gallione C, Pytel P, Liao JK, et al. RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. PMID 27879448 DOI: 10.1161/Strokeaha.116.015013 |
0.51 |
|
2015 |
Shenkar R, Shi C, Rebeiz T, Stockton RA, McDonald DA, Mikati AG, Zhang L, Austin C, Akers AL, Gallione CJ, Rorrer A, Gunel M, Min W, Marcondes de Souza J, Lee C, et al. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 17: 188-96. PMID 25122144 DOI: 10.1038/Gim.2014.97 |
0.659 |
|
2014 |
McDonald DA, Shi C, Shenkar R, Gallione CJ, Akers AL, Li S, De Castro N, Berg MJ, Corcoran DL, Awad IA, Marchuk DA. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Human Molecular Genetics. 23: 4357-70. PMID 24698976 DOI: 10.1093/Hmg/Ddu153 |
0.675 |
|
2012 |
McDonald DA, Shi C, Shenkar R, Stockton RA, Liu F, Ginsberg MH, Marchuk DA, Awad IA. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke; a Journal of Cerebral Circulation. 43: 571-4. PMID 22034008 DOI: 10.1161/Strokeaha.111.625467 |
0.659 |
|
2011 |
Dickinson RE, Griffin H, Bigley V, Reynard LN, Hussain R, Haniffa M, Lakey JH, Rahman T, Wang XN, McGovern N, Pagan S, Cookson S, McDonald D, Chua I, Wallis J, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood. 118: 2656-8. PMID 21765025 DOI: 10.1182/blood-2011-06-360313 |
0.315 |
|
2011 |
Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, Fortin A, Haniffa M, Ceron-Gutierrez L, Bacon CM, Menon G, Trouillet C, McDonald D, Carey P, Ginhoux F, et al. IRF8 mutations and human dendritic-cell immunodeficiency. The New England Journal of Medicine. 365: 127-38. PMID 21524210 DOI: 10.1056/Nejmoa1100066 |
0.329 |
|
2011 |
McDonald DA, Shenkar R, Shi C, Stockton RA, Akers AL, Kucherlapati MH, Kucherlapati R, Brainer J, Ginsberg MH, Awad IA, Marchuk DA. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Human Molecular Genetics. 20: 211-22. PMID 20940147 DOI: 10.1093/Hmg/Ddq433 |
0.669 |
|
2010 |
Jones LL, McDonald DA, Borum PR. Acylcarnitines: role in brain. Progress in Lipid Research. 49: 61-75. PMID 19720082 DOI: 10.1016/j.plipres.2009.08.004 |
0.483 |
|
Show low-probability matches. |